STOCK TITAN

Sale plan for 117,337 GDTC shares by shareholder (NASDAQ: GDTC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A GDTC shareholder filed a notice of proposed sale of 117,337 ordinary shares on NASDAQ through Bank of Singapore, with an approximate sale date of February 12, 2026. The filing notes that there were 11,733,712 ordinary shares outstanding at the time.

The seller previously disposed of ordinary shares over the past three months in three transactions, including 22,950 shares for gross proceeds of $43,889.34, 12,005 shares for $19,659.86, and 8,245 shares for $12,908.25. The shares being sold were originally acquired by share subscription from the issuer in April 2021 and paid for in cash.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the latest Form 144 filing reveal about GDTC shares?

The filing shows a GDTC shareholder plans to sell 117,337 ordinary shares on NASDAQ. These shares were acquired via a cash share subscription in April 2021, and the sale is expected around February 12, 2026, under Rule 144 conditions.

How many GDTC shares does the Form 144 holder intend to sell?

The shareholder intends to sell 117,337 GDTC ordinary shares. The notice lists Bank of Singapore as broker and NASDAQ as the exchange, with 11,733,712 ordinary shares outstanding referenced as context for the planned Rule 144 sale.

What prior GDTC share sales are disclosed in this Form 144?

The document reports three prior sales of GDTC ordinary shares in the past three months: 22,950 shares for $43,889.34, 12,005 shares for $19,659.86, and 8,245 shares for $12,908.25. These transactions provide recent trading history for the same seller.

When were the GDTC shares in this Form 144 originally acquired?

The shares were acquired on April 22, 2021 through a share subscription from the issuer. Payment was made in cash on April 20, 2021, and the current Form 144 covers a portion of that original 711,822-share acquisition.

Which broker and exchange are involved in the planned GDTC share sale?

The filing lists Bank of Singapore at 63 Market St, #22-00, Singapore as the broker. The shares are expected to be sold as ordinary shares on the NASDAQ exchange under Rule 144 requirements for resales of restricted or control securities.

What representation does the GDTC Form 144 seller make about company information?

By signing the notice, the seller represents they do not know any material adverse, non-public information about GDTC’s current or prospective operations. This representation supports compliance with securities laws governing sales by affiliates or holders of restricted securities.
CytoMed Therapeutics Ltd

NASDAQ:GDTC

GDTC Rankings

GDTC Latest News

GDTC Latest SEC Filings

GDTC Stock Data

12.20M
3.87M
68.86%
0.43%
0.29%
Biotechnology
Healthcare
Link
Singapore
Singapore